Ionis Pharmaceuticals, Inc.
Combinations for the modulation of SMN expression
Last updated:
Abstract:
Certain embodiments are directed to methods and compounds for modulating expression of SMN. In certain embodiments at least two compounds are used: a first compound for inhibiting SMN-NAT and increasing expression of SMN, and a second compound for modulating the splicing of SMN. Such methods and compounds are useful for increasing expression exon 7 containing SMN mRNA in cells and animals.
Status:
Grant
Type:
Utility
Filling date:
16 Jun 2017
Issue date:
14 Dec 2021